Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
208.6 USD | +1.88% | -1.10% | -17.43% |
May. 08 | Morgan Stanley Cuts Price Target on Penumbra to $235 From $240, Keeps Equalweight Rating | MT |
May. 07 | Penumbra Q1 Non-GAAP EPS, Revenue Increase; Reaffirms 2024 Revenue Outlook | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.43% | 7.94B | |
+73.46% | 12.4B | |
-0.92% | 6.17B | |
+16.74% | 5.55B | |
-3.21% | 5.35B | |
+46.20% | 5.03B | |
-17.73% | 4.07B | |
-29.77% | 2.65B | |
-0.74% | 1.99B | |
+35.77% | 1.93B |
- Stock Market
- Equities
- PEN Stock
- News Penumbra, Inc.
- Transcript : Penumbra, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 07